Innovation Pharmaceuticals Inc (IPIX)

[F1ash]

And just when I was beginning to think I had a pretty good handle on the situation...

" BUT their reverse split and uplisting (in Oct) didn't provide the full kick that it normally provides because it occurred after the opportunity to enter the Russell 2000 had passed (it changes every year...based on market cap on the last Friday in May...and they probably [not calculated yet]**** fell short this year based on the drop in share price and its market cap impact.

So, if I read this correctly, not only is up listing important, the timing of it may actually be more important?

Where is the anger at their CEO for up listing at the wrong time? If I read correctly he is well connected in the financial world. How did he make such a critical error. I didn't look at the exact price but it was somewhere around $9 a share on Nasdaq listing day. October 28th 2015. That other company has not suffered a single trial failure (failure is a virtual impossibility with their current trial design imho).

Their share price sits at ~$4 right now. Their short interest is over 10% and Cellceutix's is at ~1%.

If Cellceutix up-listed but missed the date like that company would the results be similar? Did that other CEO bungle their up-listing? Should one be buying that stock right now? Aren't they going to be included on the Russell 3000 very soon. As long as there is no news from the company between now and then it seems share price increase should be a virtual lock then?